B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.
about
B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcomeEndosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications.Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells.Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotypeB7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceImproved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1αThe co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.B7-H3 regulates migration and invasion in salivary gland adenoid cystic carcinoma via the JAK2/STAT3 signaling pathway.B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway.B7-H3-mediated tumor immunology: Friend or foe?MicroRNAs and photocarcinogenesis.Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma.Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer.The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.B7-H3 in tumors: friend or foe for tumor immunity?Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells.B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway.B7H3 As a Promoter of Metastasis and Promising Therapeutic TargetPredominance of triple wild-type and IGF2R mutations in mucosal melanomasLarge-scale analysis reveals the specific clinical and immune features of B7-H3 in gliomaTargeting immunotherapy for bladder cancer using anti-CD3× B7-H3 bispecific antibodyThe role of miR-29c/B7-H3 axis in children with allergic asthma
P2860
Q34105913-DDCD319A-C131-43EE-9D7E-272352BBCC89Q34481202-9731515D-E153-4749-9219-6C4B16342F78Q35104159-D4F250C2-8C08-46ED-9AB8-F0C141CE4D2FQ35867721-9A552EEF-DAF0-4A87-B3F9-06132A5E0694Q36082492-6EB56F00-419C-4AD7-B8DE-A6F7567480A9Q36419956-864A77B7-E278-49B6-B5B3-43C7E535E5B5Q36464312-CEC05A4C-06C2-4FB0-B942-AE1A85464549Q36557527-B9DAE47A-68C0-45A4-9CD3-05BB1E4A76CAQ36597354-CB16625D-EABC-40F8-9F94-64183B3EB99BQ36612452-DF878420-F197-40B1-97D1-09803500B239Q36921665-1445B744-0EEF-4A8A-BA2C-40D2C00F8998Q37362510-6B85FC2B-D8CB-4614-9E7F-D0AE3F441C49Q37474092-7BD2E966-3FF1-443A-9C89-7B7675159268Q37708952-DFB6EED0-0FD2-40C1-BD13-A16A75519CC1Q37733039-E4F22B3F-3E12-4F25-A8AE-BC984DB45CF1Q37738088-B09BE5D3-A5DD-4D19-AAD3-577960694FEAQ38135281-0F29FDB5-F24D-4D0C-A958-FDADFF3C5BA8Q38250171-E2832385-30AA-44A8-B451-03BC8FD4FFCEQ38731474-9B0E9297-66A4-4B0B-8FF0-862DA2D2398DQ38847201-21E33949-639C-458A-B3ED-060E17914A55Q38856131-ECDF820F-37E3-40AD-94FA-90259EE11998Q39160982-E005DCB3-D917-46F5-8C33-A2B25F2BE511Q41809391-E6B43E49-41FC-4AC9-AD35-6BF52C2363FBQ47150218-7C9026F9-34AD-455C-BBCC-16281187DA51Q47233613-A06C7453-45E6-4021-99F1-92E765DA9792Q48131888-E2AD39FD-CD98-4531-B029-0E0816C056DAQ53800920-4E2344C5-794D-48E0-904C-921C808D6901Q57176931-0184CB3A-5A9A-4DE4-9DEA-B7C0D5C23415Q58093307-44D1AD46-372D-4F1D-9253-A9FE442CC4CAQ58129683-4803DAC6-1ACF-4E02-A981-8A65E639DEA4Q58697139-061FA1E9-A55A-4363-B83C-9AEBEB1E3537Q58802272-1094FDDB-FC1F-4119-9200-A9F16E2A6BFD
P2860
B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
B7-H3 associated with tumor pr ...... ctivity in cutaneous melanoma.
@en
B7-H3 associated with tumor pr ...... ctivity in cutaneous melanoma.
@nl
type
label
B7-H3 associated with tumor pr ...... ctivity in cutaneous melanoma.
@en
B7-H3 associated with tumor pr ...... ctivity in cutaneous melanoma.
@nl
prefLabel
B7-H3 associated with tumor pr ...... ctivity in cutaneous melanoma.
@en
B7-H3 associated with tumor pr ...... ctivity in cutaneous melanoma.
@nl
P2093
P2860
P356
P1476
B7-H3 associated with tumor pr ...... ctivity in cutaneous melanoma.
@en
P2093
Christine Kuo
Dave S B Hoon
Donald L Morton
Jinhua Wang
Kelly K Chong
Linhda Nguyen
Sharon K Huang
Wang Zhang
Yoshitaka Nakamura
P2860
P2888
P304
P356
10.1038/JID.2013.114
P407
P577
2013-03-08T00:00:00Z